Suneva Medical Stock
Suneva Medical provides a novel and differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets.
Sign up today and learn more about Suneva Medical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Suneva Medical Stock
Suneva Medical is a privately held medical technology company focused on developing, manufacturing, and commercializing novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It provides novel and differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. The company’s flagship brand, Bellafill is the only dermal filler on the market with five-year safety and efficacy data, and the only dermal filler approved for the correction of facial acne scars. The Suneva Medical product portfolio focuses on compelling, differentiated products that deliver high patient satisfaction and represent a significant business opportunity to its practice partners. The company was founded in 2015 and headquartered in San Diego, California.
Funding History
November 2012 | $35.2M |
---|---|
September 2013 | $10.0M |
January 2014 | $20.0M |
January 2014 | $15.0M |
July 2015 | $15.0M |
July 2015 | $20.4M |
June 2016 | $25.0M |
April 2019 | $10.0M |
May 2020 | $25.1M |
Management
CFO
Joseph A. Newcomb
CEO
Pat Altavilla
Board Member
Vince Ippolito
Chief Scientific Officer
Brian Pilcher
Chief Financial Officer
Michael Brower
Board of Directors
Todd C. Davis
Board of Directors
Paul J Hadden
Board of Directors
Dan Piacquadio
Board of Directors
Brian Chee
Board of Directors
Clarke B. Futch
Press
globenewswire - Jan, 28 2024
Facial Injectable Market Size is projected to reach USD 31 ...globenewswire - Jan, 28 2024
U.S. Dermal Fillers Market Size to Surpass USD 3.61 Billion ...businesswire - Dec, 21 2023
Global Facial Injectable Market Analysis, Size & Forecast ...pharmiweb - Dec, 21 2023
Anticipated Growth: Dermal Fillers Market Projected to Expand ...finance - Dec, 21 2023
Hypertrophic And Keloid Scar Treatment Global Market Report ...